Skip to main content
HR 2629 108th Congress House Foreign Trade and International Finance Canada Commerce Compensation (Law) Customs unions Drug approvals Drug industry Drugs Free trade Government Operations and Politics Health Import restrictions Imports Labeling Latin America Mexico Pharmaceutical research Pharmacies Science, Technology, Communications Signs and symbols

New Aid for Trustworthy, Affordable Drugs Act (NAFTA Drugs Act)

Introduced: June 26, 2003 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 11, 2003
Referred to the Subcommittee on Health.
Jul 7, 2003
Referred to the Subcommittee on Trade.
Jun 26, 2003
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 26, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

New Aid for Trustworthy, Affordable Drugs Act (NAFTA Drugs Act) - Directs the United States Trade Representative (USTR) to enter into agreements with other North American Free Trade Agreement (NAFTA) countries (Canada and Mexico) to harmonize regulatory requirements such that drugs approved for commercial distribution in any NAFTA country may be imported or exported between NAFTA countries. Permits the USTR to enter into such an agreement only if the agreement provides for: (1) regulatory standards for drugs that are consistent with the requirements of this Act; (2) a seal, to be placed only by a registered pharmacy, certifying that a given drug meets the standards of the harmonization agreement and may be imported; (3) a unique system of tracking numbers identifying certain entities, including the drug manufacturer and the NAFTA county of origin; (4) the reimbursement by drug manufacturers of the Secretary of Health and Human Services for benefits derived from National Institutes of Health research.

Sets a sunset of one year after the passage of this Act for the authority of the USTR to enter into harmonization agreements under this Act.

What's happening now July 11, 2003

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 2
All 2 Democratic 1 Independent 1
D
Case, Ed
Hawaii · Jun 26, 2003
 I
Sanders, Bernard
Vermont · Jun 26, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2629: New Aid for Trustworthy, Affordable Drugs Act (NAFTA Drugs Act). 108th Congress. Open America. https://openamerica.io/bill/108-HR-2629/
MLA
"H.R. 2629: New Aid for Trustworthy, Affordable Drugs Act (NAFTA Drugs Act)." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-2629/.
Bluebook (legal)
H.R. 2629, 108th Cong. (2026), https://openamerica.io/bill/108-HR-2629/.
Markdown link
[H.R. 2629: New Aid for Trustworthy, Affordable Drugs Act (NAFTA Drugs Act)](https://openamerica.io/bill/108-HR-2629/)
Report a problem